4-aminoquinoline has been researched along with Koch's Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Abbadi, BL; Basso, LA; Bizarro, CV; Borges Martinelli, LK; Borsoi, AF; Corso Minotto, AC; da Silva Dadda, A; da Silva Rodrigues Junior, V; de Matos Czeczot, A; Denise de Moura Sperotto, N; Dias de Oliveira, S; Duarte, LS; Galina, L; Leyser, M; Macchi Hopf, FS; Machado, P; Madeira Silva, RB; Muniz, MN; Neves, CE; Paz, JD; Perelló, MA; Pissinate, K; Rambo, RS; Ramos, AS; Roth, CD | 1 |
| Chauhan, B; Khede, MK; Nandi, S; Tarannum, H | 1 |
| Alegaon, SG; Salve, PS; Sriram, D | 1 |
3 other study(ies) available for 4-aminoquinoline and Koch's Disease
| Article | Year |
|---|---|
Novel 4-aminoquinolines: Synthesis, inhibition of the Mycobacterium tuberculosis enoyl-acyl carrier protein reductase, antitubercular activity, SAR, and preclinical evaluation.
Topics: Aminoquinolines; Animals; Antitubercular Agents; Disease Models, Animal; Enzyme Inhibitors; Mice; Mycobacterium tuberculosis; NAD (+) and NADP (+) Dependent Alcohol Oxidoreductases; Tuberculosis | 2023 |
Multi-target Polypharmacology of 4-aminoquinoline Compounds against Malaria, Tuberculosis and Cancer.
Topics: Aminoquinolines; Humans; Malaria; Neoplasms; Polypharmacology; Tuberculosis | 2023 |
Three-component, one-pot synthesis of anthranilamide Schiff bases bearing 4-aminoquinoline moiety as Mycobacterium tuberculosis gyrase inhibitors.
Topics: Aminoquinolines; Animals; Antitubercular Agents; DNA Gyrase; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; ortho-Aminobenzoates; Schiff Bases; Structure-Activity Relationship; Topoisomerase II Inhibitors; Tuberculosis; Vero Cells | 2017 |